EU experts cautious on fourth dose of COVID-19
It is ‘too early’ to consider using a fourth dose of mRNA COVID-19 vaccines in the general population, according to the European Medicines Agency (EMA) and the European… read more.
It is ‘too early’ to consider using a fourth dose of mRNA COVID-19 vaccines in the general population, according to the European Medicines Agency (EMA) and the European… read more.
Open discussion of the scientific evidence and the uncertainties could have generated less political polarisation, less wasted expenditure but built more trust, according to Allyson Pollock, Clinical Professor… read more.
Covid is far less serious for children, long-covid is not a big issue and many also have natural immunity – all of which raises questions over whether children… read more.
There are several theoretical reasons for implementing vaccine passports but now that none of these apply any longer in the UK it is difficult to see a rationale… read more.
Many factors influence decisions about vaccine use including many ‘unknowns’ and this raises questions about the wisdom of targeting young people and recommending boosters for everyone, explains Allyson… read more.
There was no evidence that mass testing stopped or prevented the transmission of covid-19, according to Professor Allyson Pollock, Clinical Professor of Public Health, Newcastle University. “Mass testing… read more.
As the coronavirus pandemic appears to be running out of steam it is important to review the lessons learned and move forward to ‘living with the virus’. IMI… read more.
Medication order errors are a significant, and preventable, public health problem. The widespread deployment of electronic health records and computerized order entry systems has largely reduced medication order… read more.
COVID-19 has had a devastating impact on people’s physical and mental health and has caused economic hardship. However, this adversity has disproportionately hurt certain populations—including essential workers and… read more.